Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Jan;87(1):208–212. doi: 10.1172/JCI114973

Synthesis and secretion of an atriopeptin-like protein in rat kidney cell culture.

D Ritter 1, P Needleman 1, J E Greenwald 1
PMCID: PMC295028  PMID: 1824632

Abstract

The synthesis and secretion of an atriopeptin(AP)-like prohormone (AP126ir) has been demonstrated in rat neonatal renal cell cultures. AP126ir could be detected in the cellular extract and the medium from cultured kidney cells of neonatal and adult rats using an enzyme immunoassay specific for cardiac AP prohormone. On reverse-phase high-performance liquid chromatography, the AP obtained from the extract and the medium comigrated with cardiac AP prohormone. Incubation of the renal AP in the medium with thrombin resulted in the generation of a single low molecular mass peak which migrated with the cardiac carboxy-terminal 28-amino acid AP. Neonatal kidney cells pulsed with [35S]methionine secreted radiolabeled AP126ir, which was detected by immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis chromatography. Incubation of neonatal kidney cell cultures with the protein synthesis inhibitor cycloheximide resulted in a significant decrease in both the cellular and media AP. No decrease in cellular and media AP was detected when neonatal atrial cultures were treated with cycloheximide. These data demonstrate the de novo synthesis of an AP prohormone-like protein in neonatal rat kidney cultures. Furthermore, unlike the atria, kidney cells appear to secrete AP solely by constitutive means. In primary adult rat kidney cultures, most of AP126ir was detected in the cortical tubule fraction demonstrating that these cells secrete AP126ir in the adult rat kidney. We hypothesize that the renal AP may be important as an autocrine or paracrine regulator of renal function.

Full text

PDF
208

Images in this article

210Image
on p.210
211Image
on p.211

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloch K. D., Seidman J. G., Naftilan J. D., Fallon J. T., Seidman C. E. Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways. Cell. 1986 Dec 5;47(5):695–702. doi: 10.1016/0092-8674(86)90512-x. [DOI] [PubMed] [Google Scholar]
  2. Kangawa K., Tawaragi Y., Oikawa S., Mizuno A., Sakuragawa Y., Nakazato H., Fukuda A., Minamino N., Matsuo H. Identification of rat gamma atrial natriuretic polypeptide and characterization of the cDNA encoding its precursor. Nature. 1984 Nov 8;312(5990):152–155. doi: 10.1038/312152a0. [DOI] [PubMed] [Google Scholar]
  3. Koehn J. A., Norman J. A., Jones B. N., LeSueur L., Sakane Y., Ghai R. D. Degradation of atrial natriuretic factor by kidney cortex membranes. Isolation and characterization of the primary proteolytic product. J Biol Chem. 1987 Aug 25;262(24):11623–11627. [PubMed] [Google Scholar]
  4. Lang R. E., Thölken H., Ganten D., Luft F. C., Ruskoaho H., Unger T. Atrial natriuretic factor--a circulating hormone stimulated by volume loading. Nature. 1985 Mar 21;314(6008):264–266. doi: 10.1038/314264a0. [DOI] [PubMed] [Google Scholar]
  5. Lovett D. H., Sterzel R. B., Kashgarian M., Ryan J. L. Neutral proteinase activity produced in vitro by cells of the glomerular mesangium. Kidney Int. 1983 Feb;23(2):342–349. doi: 10.1038/ki.1983.25. [DOI] [PubMed] [Google Scholar]
  6. Marumo F., Sakamoto H., Ando K., Ishigami T., Kawakami M. A highly sensitive radioimmunoassay of atrial natriuretic peptide (ANP) in human plasma and urine. Biochem Biophys Res Commun. 1986 May 29;137(1):231–236. doi: 10.1016/0006-291x(86)91200-3. [DOI] [PubMed] [Google Scholar]
  7. McLaughlin L. L., Wei Y. F., Stockmann P. T., Leahy K. M., Needleman P., Grassi J., Pradelles P. Development, validation and application of an enzyme immunoassay (EIA) of atriopeptin. Biochem Biophys Res Commun. 1987 Apr 14;144(1):469–476. doi: 10.1016/s0006-291x(87)80533-8. [DOI] [PubMed] [Google Scholar]
  8. Michener M. L., Gierse J. K., Seetharam R., Fok K. F., Olins P. O., Mai M. S., Needleman P. Proteolytic processing of atriopeptin prohormone. Mol Pharmacol. 1986 Dec;30(6):552–557. [PubMed] [Google Scholar]
  9. Murphy K. M., McLaughlin L. L., Michener M. L., Needleman P. Autoradiographic localization of atriopeptin III receptors in rat kidney. Eur J Pharmacol. 1985 May 8;111(2):291–292. doi: 10.1016/0014-2999(85)90772-1. [DOI] [PubMed] [Google Scholar]
  10. Needleman P., Blaine E. H., Greenwald J. E., Michener M. L., Saper C. B., Stockmann P. T., Tolunay H. E. The biochemical pharmacology of atrial peptides. Annu Rev Pharmacol Toxicol. 1989;29:23–54. doi: 10.1146/annurev.pa.29.040189.000323. [DOI] [PubMed] [Google Scholar]
  11. Sakamoto M., Nakao K., Kihara M., Morii N., Sugawara A., Suda M., Shimokura M., Kiso Y., Yamori Y., Imura H. Existence of atrial natriuretic polypeptide in kidney. Biochem Biophys Res Commun. 1985 May 16;128(3):1281–1287. doi: 10.1016/0006-291x(85)91079-4. [DOI] [PubMed] [Google Scholar]
  12. Schulz-Knappe P., Forssmann K., Herbst F., Hock D., Pipkorn R., Forssmann W. G. Isolation and structural analysis of "urodilatin", a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr. 1988 Sep 1;66(17):752–759. doi: 10.1007/BF01726570. [DOI] [PubMed] [Google Scholar]
  13. Schwartz D., Geller D. M., Manning P. T., Siegel N. R., Fok K. F., Smith C. E., Needleman P. Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptide. Science. 1985 Jul 26;229(4711):397–400. doi: 10.1126/science.3160114. [DOI] [PubMed] [Google Scholar]
  14. Shima M., Seino Y., Torikai S., Imai M. Intrarenal localization of degradation of atrial natriuretic peptide in isolated glomeruli and cortical nephron segments. Life Sci. 1988;43(4):357–363. doi: 10.1016/0024-3205(88)90113-0. [DOI] [PubMed] [Google Scholar]
  15. Wilkins M. R., Settle S. L., Needleman P. Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation. J Clin Invest. 1990 Apr;85(4):1274–1279. doi: 10.1172/JCI114564. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES